Skip to content

Quality of Life After Routine Nasogastric Decompression After Distal Gastrectomy for Gastric Cancer Patients

Phase III Study for the Significance of Nasogastric Decompression Tube After Curative Distal Gastrectomy for Gastric Cancer Patients

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00738478
Enrollment
180
Registered
2008-08-20
Start date
2006-02-28
Completion date
2008-12-31
Last updated
2009-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Keywords

distal gastrectomy, quality of life

Brief summary

The aim of the study is to evaluate whether distal gastrectomy without post-operative nasogastric decompression tube is better in terms of quality of life.

Detailed description

Nasogastric decompression tube is an intra-operative routine in most of the time to facilitate exposure of operative field during elective distal gastrectomy, however, whether it should be retained post-operatively is controversial. Nasogastric decompression tube helps to drain the gastric remnant in case there is edema around the gastrojejunostomy, ileus and delayed gastric emptying, which can theoretically relieve nausea and abdominal distension. However, nasogastric intubation could cause patients discomfort; also it has been shown that it would cause gastroesophageal reflux which may be associated with pulmonary complication.

Interventions

DEVICEnasogastric tube

insertion of nasogastric tube for 2 days after operation

DEVICEwithout nasogastric tube

without nasogastric tube after operation

Sponsors

Wakayama Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* on the basis of whether distal gastrectomy was anticipated at WMUH for gastric cancer.

Exclusion criteria

* patients who were diagnosed inadequacy for this study by a physician. * patients without an informed consent.

Design outcomes

Primary

MeasureTime frame
Quality of lifeseven days after operation

Secondary

MeasureTime frame
complication, hematological data,the time of discharge

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026